the company has been pretty open about its plan to partner CDH17 since Rebecca joined as COO/CEO. We just need more safety / efficacy data which will be available in the next few months.
Given the GI cancer market is approx USD25bn, big pharma will be climbing over themselves to get into bed with us (IF we deliver strong early data).
CHM Price at posting:
0.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)